(9/1/21) Every drug certified by the FDA must be tested using the horseshoe crab derivative known as Limulus lysate. Because of this, a multimillion-dollar industry has emerged involving the license to bleed horseshoe crabs and the rights to their breeding grounds. In the latest edition of his book Crab Wars: A Tale of Horseshoe Crabs, Ecology, and Human Health, William Sargent breaks down this exploitation of the horseshoe crab at the hands of multinational pharmaceutical conglomerates. Join us for a look at an issue with profound implications not only for the future of the crabs themselves but for the ecosystems that depend on them in this installment of Leonard Lopate at Large on WBAI.